Abstract
Chronic obstructive pulmonary disease (COPD) currently ranks as the fourth cause of death in the United States and it is an increasingly important health problem for the rest of the world [1-3]. Its prevalence has increased as overall mortality from myocardial infarction and cerebro-vascular accident, the two organ system affected by the same risk factor (namely cigarette smoking), have decreased. Although preventable and treatable, once diagnosed and symptomatic COPD is progressive and in some patients leads to disability usually due to dyspnea, at a relatively early age (6th or 7th decade) [4,5]. Limitation to airflow occurs as a consequence of destruction of lung parenchyma or to alterations in the airway itself. One of the most important consequences is the development of static and dynamic hyperinflation with important clinical consequences such as dyspnea with exercise and decreased survival. This chapter integrates the pathologic changes of COPD with the known adaptive and maladaptive consequences of those changes. These factors should help us understand the rationale behind the therapeutic strategies aimed at decreasing lung volume and addressing the complications of patients with COPD.
Keywords: Dyspnea, dynamic hyperinflation, respiratory drive, oxygen, flow limitation, respiratory muscles, lung volume reduction surgery
Current Respiratory Medicine Reviews
Title: Lung Volume Reduction in Patients with COPD: Physiological and Clinical Implications
Volume: 4 Issue: 4
Author(s): Bartolome R. Celli
Affiliation:
Keywords: Dyspnea, dynamic hyperinflation, respiratory drive, oxygen, flow limitation, respiratory muscles, lung volume reduction surgery
Abstract: Chronic obstructive pulmonary disease (COPD) currently ranks as the fourth cause of death in the United States and it is an increasingly important health problem for the rest of the world [1-3]. Its prevalence has increased as overall mortality from myocardial infarction and cerebro-vascular accident, the two organ system affected by the same risk factor (namely cigarette smoking), have decreased. Although preventable and treatable, once diagnosed and symptomatic COPD is progressive and in some patients leads to disability usually due to dyspnea, at a relatively early age (6th or 7th decade) [4,5]. Limitation to airflow occurs as a consequence of destruction of lung parenchyma or to alterations in the airway itself. One of the most important consequences is the development of static and dynamic hyperinflation with important clinical consequences such as dyspnea with exercise and decreased survival. This chapter integrates the pathologic changes of COPD with the known adaptive and maladaptive consequences of those changes. These factors should help us understand the rationale behind the therapeutic strategies aimed at decreasing lung volume and addressing the complications of patients with COPD.
Export Options
About this article
Cite this article as:
Celli R. Bartolome, Lung Volume Reduction in Patients with COPD: Physiological and Clinical Implications, Current Respiratory Medicine Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339808786263734
DOI https://dx.doi.org/10.2174/157339808786263734 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nitric Oxide and Dietary Factors: Part III Minerals, Vitamins and Other Dietary and Lifestyle Factors
Vascular Disease Prevention (Discontinued) Autonomic Nervous System Alterations in Rett Syndrome
Current Pediatric Reviews Hypoxia and Fetal Heart Development
Current Molecular Medicine Hyponatraemia Associated with Trimethoprim Use
Current Drug Safety Conventional Chemotherapy and Emerging Targeted Therapy for Advanced Adrenocortical Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Review: New Anti-Cytokines for IBD: What is in the Pipeline?
Current Drug Targets Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Gene Electrotransfer: A Mechanistic Perspective
Current Gene Therapy Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes
Current Vascular Pharmacology Levosimendan: A Novel Agent in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Glucose Metabolism and Antidepressant Medication
Current Pharmaceutical Design Development and Evaluation of High Bioavailable Sustained-Release Nimodipine Tablets Prepared with Monolithic Osmotic Pump Technology
Current Drug Delivery Antifungal Prophylaxis in the Preterm Infant
Current Pediatric Reviews Pharmacological Adjuvant Therapies in Primary Coronary Interventions: Bivalirudin
Cardiovascular & Hematological Agents in Medicinal Chemistry A Historical Overview on Coronary Surgery and Interventional Cardiology: Parallel Pathways?
Vascular Disease Prevention (Discontinued) New Therapies for Sepsis
Current Topics in Medicinal Chemistry Renal Protective Effect of Metabolic Therapy in Patients with Coronary Artery Disease and Diabetes: From Bench to Bed Side
Current Pharmaceutical Design Gadolinium-Contrast Toxicity in Patients with Kidney Disease: Nephrotoxicity and Nephrogenic Systemic Fibrosis
Current Drug Safety Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Implications In Anesthesia Practice
Current Pharmaceutical Design Long-Term Use of Short- and Long-Acting Nitrates in Stable Angina Pectoris
Current Clinical Pharmacology